Clinical trial
Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity
NCT00264186 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00264186 |
|---|---|
| Title | Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity |
| Official title | Impact of rhCu/Zn SOD on Inflammation-Induced Impairment of Vascular Reactivity |
| Lead sponsor | Medical University of Vienna, Other |
| Collaborators | Polymun Scientific, Vienna, Austria |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Inflammation |
| Intervention type | Drug |
| Interventions | LPS 2 ng/kg intravenous (IV) bolus, rhSOD 82, 000 IU (8.2 mg)/min intraarterially, Norepinephrine 60, 120, 240 pmol/min intraarterially over 5 min/dose level (two times, pre-dose and +3.5 hrs), Acetylcholine 6.25, 12.5, 25 nmol/min intraarterially over 3 min/dose level (two times and 3 more |
| Enrollment | 43 |
| Start date | Jun 1, 2005 |
| First posted | Dec 12, 2005 |
| Last update posted | May 22, 2008 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: